\
&
Contact us
\
&
Contact us
This was 1 year ago
Locationhybrid
The Polish National Centre for Research and Development (NCBR) and Business and Science Poland (BSP) offices in Brussels organise a talk with Mr. Bruno Maquart, President of the European Network of Science Centres and Museums (ECSITE) and Chairman & CEO of Universcience. The topic of the talk is citizens’ engagement in research & innovation, more specifically in the EU Missions and Horizon Europe, and questions that will be tackled are:
Registration for the talk is required by 26 September. In the registration form you can indicate the type of presence (at the venue or online) and submit questions for the speaker.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
